2018
20/12/2018 Mayne Pharma extends debt facility and adds receivables facility
17/12/2018 Mayne Pharma announces US commercial rights for Suba®-Itraconazole in BCCNS
12/12/2018 Mayne Pharma receives FDA approval of TolsuraTM
29/10/2018 Retirement of Director
26/10/2018 Mayne Pharma Acquires FDA-Approved Halobetasol Foam, Complementing US Dermatology Portfolio
24/08/2018 Mayne Pharma FY18 Results Media Release
30/07/2018 Mayne Pharma Launches Butalbital Acetaminophen Capsules in the United States
23/07/2018 Mayne Pharma Acquires Generic Efudex®, Complementing US Dermatology Portfolio
16/07/2018 Mayne Pharma Launches Generic Kapvay® in the U.S.
28/06/2018 Mayne Pharma further strengthens Board with new Director
30/05/2018 Mayne Pharma strengthens Board with new Director
16/04/2018 Mayne Pharma Launches Amiodarone Tablets 200mg in the United States
26/03/2018 Mayne Pharma Launches Generic Quartette® in the U.S., Another Women's Health Product
20/03/2018 Mayne Pharma’s Generic Nuvaring® Anda Accepted for Filing by FDA
15/03/2018 Mayne Pharma Launches Doxycycline IR Capsules in the US, Generic Monodox
23/02/2018 HY18 Results Media Release (PDF)